Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Case Study: Understanding the patient journey and addiction treatment pathways

    White Papers and Resources | November 23, 2016 | Inizio

    Our client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and...

    Research Partnership has published a new Living with Chronic Pain market report for 2016

    White Papers and Resources | November 23, 2016 | Inizio

    Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients...

    Nutraceuticals: Rich in Potential

    White Papers and Resources | November 23, 2016 | Inizio

    Published in eyeforpharma October 2016 by Marc Yates

    Case Study: Qualitative research with payers in low and middle income countries

    White Papers and Resources | November 23, 2016 | Inizio

    Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in...

    Webinar – Immuno-oncology’s Evolution: Implications for Pharma Market Researchers

    White Papers and Resources | November 23, 2016 | Inizio

    In association with PMGroup

    Case study: Leveraging Market Research Data to Inform Healthcare Providers and the Community

    White Papers and Resources | November 23, 2016 | Inizio

    Our client wanted to understand why uptake of HPV vaccination in the Asia-Pacific region was limited.  In order to help increase uptake, they wanted to publish the market research findings...

    Towards a culture of evaluation and evidence-based decision making in global health

    White Papers and Resources | November 23, 2016 | Inizio

    Reflections on THET Conference 2016: Evidence, Effectiveness & Impact

    Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016

    White Papers and Resources | November 23, 2016 | Inizio

    Ulcerative Colitis (UC) is a progressive and debilitating disease which affects between 2.5 to 3 million people in Europe. Living with UC is a quantitative study conducted online amongst 325 patients, including...

    The Internet of Things

    White Papers and Resources | November 23, 2016 | Inizio

    Evolution from man to machine

    Therapy Watch expands its oncology portfolio

    White Papers and Resources | November 23, 2016 | Inizio

    This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio...